Dry Eye Related to Commonly Used New Antidepressants. (Record no. 24982943)

MARC details
000 -LEADER
fixed length control field 01410 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517035357.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201604s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1533-712X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1097/JCP.0000000000000356
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Koçer, Emel
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20160418
245 00 - TITLE STATEMENT
Title Dry Eye Related to Commonly Used New Antidepressants.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of clinical psychopharmacology
Date of publication, distribution, etc. Aug 2015
300 ## - PHYSICAL DESCRIPTION
Extent 411-3 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adrenergic Uptake Inhibitors
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antidepressive Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Case-Control Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Citalopram
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dry Eye Syndromes
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Follow-Up Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Paroxetine
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Selective Serotonin Reuptake Inhibitors
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Venlafaxine Hydrochloride
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Koçer, Abdulkadir
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Özsütçü, Mustafa
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dursun, Ali Emre
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Krpnar, İsmet
773 0# - HOST ITEM ENTRY
Title Journal of clinical psychopharmacology
Related parts vol. 35
-- no. 4
-- p. 411-3
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1097/JCP.0000000000000356">https://doi.org/10.1097/JCP.0000000000000356</a>
Public note Available from publisher's website

No items available.